• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于血管和肿瘤成像的高性能聚合物钆基磁共振成像造影剂的手性开发策略

Chiral Strategy for Developing High-Performance Polymeric Gadolinium-Based MRI Contrast Agents for Vascular and Tumor Imaging.

作者信息

Zhou Xinlan, Ruan Xinzhong, Li Xingjiang, Xu Weiyuan, Xiao Xinhui, Chen Aiyi, Ding Yinghui, Zhang Jilai, Mo Gengshen, Jian Yong, Wu Xinyang, Ye Fangfu, Wang Zhiqiang, Li Yi, Dai Lixiong

机构信息

Key Laboratory of Theoretical Organic Chemistry and Function Molecule, Ministry of Education, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan 411201, China.

Wenzhou Key Laboratory of Biophysics, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang 325001, China.

出版信息

Chem Biomed Imaging. 2025 Apr 1;3(6):387-397. doi: 10.1021/cbmi.5c00012. eCollection 2025 Jun 23.

DOI:10.1021/cbmi.5c00012
PMID:40575086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12188411/
Abstract

Magnetic resonance imaging (MRI) is a critical tool in medical diagnostics, yet conventional MRI contrast agents (CAs) are often limited by their small-molecule nature, resulting in rapid clearance and low relaxivity. This study presents a chiral strategy for developing high-performance polymeric gadolinium-based CAs, PAA-EOB-GdA and PAA-EOB-GdB, tailored for enhanced vascular and tumor imaging. Notably, PAA-EOB-GdA, a chiral Gd-DOTA derivative integrated with sodium poly-(acrylic acid) (PAA), benefits from the optimized water exchange rate of chiral Gd-(III) complex and the polymer effect of PAA, exhibiting exceptionally high relaxivity ( = 37.87 mM s, 11.9-fold of clinical Gd-DOTA) and showed remarkable imaging efficacy in magnetic resonance angiography (MRA) with low-dose administration (0.05 mmol kg) and an extended imaging duration. Its performance in tumor imaging was also impressive, maintaining superior enhancement values compared to Gd-DOTA. These characteristics feature PAA-EOB-GdA as a promising candidate for clinical diagnosis in both vascular and tumor imaging applications.

摘要

磁共振成像(MRI)是医学诊断中的关键工具,但传统的MRI造影剂(CAs)往往因其小分子性质而受到限制,导致快速清除和低弛豫率。本研究提出了一种手性策略,用于开发高性能的基于钆的聚合物造影剂PAA-EOB-GdA和PAA-EOB-GdB,专为增强血管和肿瘤成像而设计。值得注意的是,PAA-EOB-GdA是一种与聚(丙烯酸)钠(PAA)整合的手性钆-多胺大环配合物衍生物,受益于手性钆(III)配合物优化的水交换速率和PAA的聚合物效应,表现出极高的弛豫率( = 37.87 mM s,是临床用钆-多胺大环配合物的11.9倍),并在低剂量给药(0.05 mmol kg)和延长成像时间的磁共振血管造影(MRA)中显示出显著的成像效果。其在肿瘤成像中的表现也令人印象深刻,与钆-多胺大环配合物相比,保持了更高的增强值。这些特性使PAA-EOB-GdA成为血管和肿瘤成像应用临床诊断的有希望的候选者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d0/12188411/6cae42084aa9/im5c00012_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d0/12188411/fef979a649af/im5c00012_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d0/12188411/cf35254d54d3/im5c00012_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d0/12188411/5fa5135d7a01/im5c00012_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d0/12188411/6f8903aec97f/im5c00012_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d0/12188411/6cae42084aa9/im5c00012_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d0/12188411/fef979a649af/im5c00012_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d0/12188411/cf35254d54d3/im5c00012_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d0/12188411/5fa5135d7a01/im5c00012_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d0/12188411/6f8903aec97f/im5c00012_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61d0/12188411/6cae42084aa9/im5c00012_0005.jpg

相似文献

1
Chiral Strategy for Developing High-Performance Polymeric Gadolinium-Based MRI Contrast Agents for Vascular and Tumor Imaging.用于血管和肿瘤成像的高性能聚合物钆基磁共振成像造影剂的手性开发策略
Chem Biomed Imaging. 2025 Apr 1;3(6):387-397. doi: 10.1021/cbmi.5c00012. eCollection 2025 Jun 23.
2
Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation.正电子发射断层扫描(PET)和磁共振成像(MRI)在早期乳腺癌腋窝淋巴结转移评估中的应用:系统评价和经济评估。
Health Technol Assess. 2011 Jan;15(4):iii-iv, 1-134. doi: 10.3310/hta15040.
3
Characterizing Breast Tumor Heterogeneity Through IVIM-DWI Parameters and Signal Decay Analysis.通过体素内不相干运动扩散加权成像(IVIM-DWI)参数和信号衰减分析表征乳腺肿瘤异质性
Diagnostics (Basel). 2025 Jun 12;15(12):1499. doi: 10.3390/diagnostics15121499.
4
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
Gadoxetic acid disodium-enhanced magnetic resonance imaging outperformed multidetector computed tomography in diagnosing small hepatocellular carcinoma: A meta-analysis.钆塞酸二钠增强磁共振成像在诊断小肝细胞癌方面优于多排螺旋 CT:一项荟萃分析。
Liver Transpl. 2017 Dec;23(12):1505-1518. doi: 10.1002/lt.24867.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.用于治疗符合抗逆转录病毒治疗条件的孕妇艾滋病毒感染的抗逆转录病毒疗法。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
10
Gd-EOB-DTPA-enhanced MRI radiomics and deep learning models to predict microvascular invasion in hepatocellular carcinoma: a multicenter study.钆塞酸二钠增强磁共振成像的影像组学和深度学习模型预测肝细胞癌微血管侵犯:一项多中心研究
BMC Med Imaging. 2025 Mar 31;25(1):105. doi: 10.1186/s12880-025-01646-9.

本文引用的文献

1
Single-point mutated lanmodulin as a high-performance MRI contrast agent for vascular and kidney imaging.单点突变的 lanmodulin 作为一种高性能 MRI 对比剂,用于血管和肾脏成像。
Nat Commun. 2024 Nov 13;15(1):9834. doi: 10.1038/s41467-024-54167-4.
2
Nanoparticle-Based Activatable MRI Probes for Disease Imaging and Monitoring.用于疾病成像与监测的基于纳米颗粒的可激活磁共振成像探针
Chem Biomed Imaging. 2023 Mar 29;1(3):192-204. doi: 10.1021/cbmi.3c00024. eCollection 2023 Jun 26.
3
Rational Design of Mono-Substituted Gd-DOTA as Highly Stable and Efficient MRI Contrast Agents for Hepatobiliary and Inflammation Imaging.
单取代 Gd-DOTA 的合理设计作为用于肝胆和炎症成像的高稳定性和高效 MRI 对比剂。
J Med Chem. 2024 Sep 12;67(17):15476-15493. doi: 10.1021/acs.jmedchem.4c01084. Epub 2024 Aug 27.
4
Chiral Pyclen-Based Heptadentate Chelates as Highly Stable MRI Contrast Agents.手性 Pyclen 基七齿螯合剂作为高稳定性 MRI 造影剂。
Inorg Chem. 2024 May 6;63(18):8462-8475. doi: 10.1021/acs.inorgchem.4c01028. Epub 2024 Apr 20.
5
PEGylated Amphiphilic Gd-DOTA Backboned-Bound Branched Polymers as Magnetic Resonance Imaging Contrast Agents.聚乙二醇化两亲性钆-多胺多羧基大环配体键合支化聚合物作为磁共振成像造影剂
Biomacromolecules. 2023 Dec 11;24(12):5998-6008. doi: 10.1021/acs.biomac.3c00987. Epub 2023 Nov 9.
6
Non-invasive Diagnosis and Postoperative Evaluation of Carotid Artery Stenosis by BSA-GdO Nanoparticles-Based Magnetic Resonance Angiography.基于 BSA-GdO 纳米颗粒的磁共振血管造影术对颈动脉狭窄的无创诊断及术后评估。
ACS Appl Bio Mater. 2023 Nov 20;6(11):4906-4913. doi: 10.1021/acsabm.3c00623. Epub 2023 Nov 2.
7
Chiral Gd-DOTA as a Versatile Platform for Hepatobiliary and Tumor Targeting MRI Contrast Agents.手性 Gd-DOTA 作为用于肝胆和肿瘤靶向 MRI 造影剂的多功能平台。
J Med Chem. 2023 Nov 9;66(21):14669-14682. doi: 10.1021/acs.jmedchem.3c01183. Epub 2023 Oct 19.
8
Hypersensitive MR angiography based on interlocking stratagem for diagnosis of cardiac-cerebral vascular diseases.基于连锁策略的高敏磁共振血管成像在心脏脑血管疾病诊断中的应用。
Nat Commun. 2023 Oct 2;14(1):6149. doi: 10.1038/s41467-023-41783-9.
9
Evaluating Dual-Targeted ECO/siRNA Nanoparticles against an Oncogenic lncRNA for Triple Negative Breast Cancer Therapy with Magnetic Resonance Molecular Imaging.评估双靶点ECO/siRNA纳米颗粒针对一种致癌长链非编码RNA用于三阴性乳腺癌治疗及磁共振分子成像
Chem Biomed Imaging. 2023 Mar 21;1(5):461-470. doi: 10.1021/cbmi.3c00011. eCollection 2023 Aug 28.
10
Rational Design of Gd-DOTA-Type Contrast Agents for Hepatobiliary Magnetic Resonance Imaging.用于肝胆磁共振成像的 Gd-DOTA 型造影剂的合理设计。
J Med Chem. 2023 Jul 13;66(13):8993-9005. doi: 10.1021/acs.jmedchem.3c00579. Epub 2023 Jun 27.